Xeris Biopharma Holdings, Inc.

Q4 2024 13F Holders

Symbol
XERS
CUSIP
98422E103
Type
Equity
Class
COM
Num filings
170
Total reported value, excl. options
$223 M
Manager Report Date Value ($000) Shares Option Type